A. The guest you heard was Dr. Sotirios “Sam” Tsimikas. He is one of the world’s foremost experts on Lp (a). People who have ...
Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.
The Brighterside of News on MSN
Low-dose aspirin lowers heart attack and stroke risk in Type 2 diabetics.
A new study presented at the American Heart Association’s Scientific Sessions 2025 found that people with Type 2 diabetes and ...
Health and Me on MSN
Can A Daily Low-Dose Aspirin Protect Diabetic Patients From Heart Disease? Here’s What Research Shows
A new American Heart Association study suggests that low-dose aspirin may lower the risk of heart attack, stroke, and death ...
I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing with your doctor. Dr. Roach: Would it be risky to take a low dose (20 mg ...
Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...
Clonal hematopoiesis of indeterminate potential was not associated with an increased risk for heart disease but was linked to ...
I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing ...
Ready, set, save! Become a Tom's Guide member and start saving on your Black Friday shopping now. Members get access to our range of exclusive offers, rewards, competitions, games and more. For ...
MELBOURNE — For decades, doctors have debated whether older adults should take a daily aspirin to prevent cancer. New research reveals they may have been asking the wrong question. Instead of ...
A de-escalated DAPT regimen following coronary artery bypass grafting provided similar graft occlusion rates compared with standard DAPT while reducing bleeding. “Saphenous vein grafts (SVGs) remain ...
In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding without compromising ischemic protection after percutaneous coronary intervention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results